Considerable on MSN
GSK buys Rapt in $2.2B deal
GSK agreed to acquire Rapt Therapeutics for $2.2 billion on Tuesday, a move that ...
If you are wondering whether GSK shares still offer value at around £18.86, you are not alone. The stock has been attracting ...
There is a significant gap in patients’ understanding of treatment options for gynecologic cancers, according to a survey conducted by The Harris Poll on behalf of GSK. In a poll of more than 800 ...
GSK plc (NYSE:GSK) is included among the 11 Best FTSE Dividend Stocks to Buy Right Now. Image by Alexsander-777 from Pixabay GSK plc (NYSE:GSK) is a major global healthcare company with operations ...
GSK Plc (NYSE:GSK) has filed a lawsuit against Moderna, Inc. (NASDAQ:MRNA) and its affiliates, alleging that Moderna’s mRNA vaccines infringe on patents developed by GSK. According to GSK, the ...
GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal antibody that targets interleukin-5, as an add-on ...
GSK plc's stock downgraded from “Buy” to “Hold” due to litigation risks, disappointing RSV vaccine sales, and competitive pressures in the HIV space. Despite strong cash flow, GSK's Zantac litigation ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results